covid-19November 6, 2020 New Alzheimer’s drug rejected by FDA panel There’s not enough evidence that the experimental drug known as aducanumab works, government health advisors said Friday. Related posts U.K.'s Johnson launches mass testing…Do you need a Covid-19…What's behind workers' hesitation to…Fully vaccinated people can travel…Younger Latino men are Covid's…Salmonella infections in eight states…Salmonella infections in eight states…The U.S. isn't losing to…Virus-killing robot tested for use…In Covid fight, Cuba touts…